Maria Saito‐Benz

Maria Saito‐Benz

Auto-generated profile, based on publicly available information

Maria Saito‐Benz

Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2019 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
MSMaria Saito‐Benz
Maria Saito‐Benz
PFPeter Flanagan
Peter Flanagan
MBMary Berry
Mary Berry

28 March 2022 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
MSMaria Saito-Benz
Maria Saito-Benz
KBKaren Bennington
Karen Bennington
CGClint L. Gray
Clint L. Gray
WMWilliam G. Murphy
William G. Murphy
PFPeter Flanagan
Peter Flanagan
MBMary J. Berry
Mary J. Berry
Preterm infants in neonatal intensive care units (NICUs), particularly those with extremely low birth weight (<1000 g), almost invariably require multiple transfusions of red blood cells (RBCs) before their estimated term birth date.1-3 Most blood transfusions are provided to medically stable infants with chronic anemia (anemia of prematurity), with the aim of increasing oxygen delivery to the metabolically active organs during the critical phase of growth and neurodevelopment. Some infants in NICUs may receive up to 200% cumulative replacement of their total circulating volume at birth by means of transfusion.4 Therefore, ensuring both the safety and efficacy of this common clinical intervention is of utmost importance.

23 September 2018 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
PDF file
MSMaria Saito‐Benz
Maria Saito‐Benz
MSMeghan E Sandle
Meghan E Sandle
PJPaul B Jackson
Paul B Jackson
MBMary J Berry
Mary J Berry

30 August 2018 in Transfusion
Verified
Journal Article
Closed access
PDF file
MSMaria Saito‐Benz
Maria Saito‐Benz
WMWilliam G. Murphy
William G. Murphy
YTYu‐Chieh Tzeng
Yu‐Chieh Tzeng
GAGreg Atkinson
Greg Atkinson
MBMary J. Berry
Mary J. Berry

29 October 2018 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
MSMaria Saito‐Benz
Maria Saito‐Benz
CGClint Gray
Clint Gray
YTYu‐Chieh Tzeng
Yu‐Chieh Tzeng
GAGreg Atkinson
Greg Atkinson
MBMary Berry
Mary Berry

19 March 2019 in Neonatology
Verified
Journal Article
Closed access
PDF file
MSMaria Saito-Benz
Maria Saito-Benz
SCSarah Cody
Sarah Cody
FDFiona Dineen
Fiona Dineen
JMJelena Mladenovic
Jelena Mladenovic
MBMary J. Berry
Mary J. Berry
Background: Moderate therapeutic hypothermia (TH) initiated within 6 h of life reduces adverse neurodevelopmental outcomes in infants after perinatal hypoxic ischaemic insult. For infants born in non-tertiary centres, TH may be initiated manually en route to a neonatal intensive care unit (NICU). However, both over- and undercooling is reported with this strategy, precluding some infants from the benefits of TH. Objectives: To evaluate the impact of a region-wide educational programme on the safety and efficacy of manual cooling administered by the Wellington Neonatal Transport Service (NeTS). Methods: Clinical records of infants with hypoxic ischaemic encephalopathy (HIE) retrieved by the Wellington NeTS for TH between January 2012 and June 2017 were reviewed retrospectively. Temperature outcomes of infants retrieved before and after the education programme were compared. Results: A total of 101 infants were cooled manually by Wellington NeTS for TH during the study period. Education and training significantly reduced the rate of overcooling to ≤32.0°C (4/43 [9%] vs. 0/58, p = 0.02). However, there was no difference in the proportion of infants who achieved target rectal temperature within 6 h of life (29/43 [65%] vs. 35/58 [60%], p = 0.57). Conclusions: Introduction of a region-wide educational programme may have improved the safety of manual cooling during neonatal transport but it had a negligible impact on its efficacy. The use of servo-controlled cooling during transport should therefore be considered to improve access to the optimal neuroprotective benefits of TH for outborn infants with HIE.